ABBV

AbbVie Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-20

Figures on this page computed 2026-11-08 12:24 UTC

Last close

288.24USD

Market data, 2026-11-05

Except where said otherwise: 10-K for 2025, filed 2026-02-20

122.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-20
The filing itself
16.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
The filing itself
6.9%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
29.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
The filing itself
2.4%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-02-20

Price is the furthest below its sector's middle: 0.10 against 0.33 on the market's range.

All from 100

lens 2 of 9

Sales

239

2016-12-31 to 2025-12-31100 at the start239

Sales: 100.00 on 2016-12-31 to 238.55 on 2025-12-31, up 139%.

Profit

71.0

2016-12-31 to 2025-12-31100 at the start71.0

Profit: 100.00 on 2016-12-31 to 70.99 on 2025-12-31, down 29%.

Shares in issue

109

2016-12-31 to 2025-12-31100 at the start109

Shares in issue: 100.00 on 2016-12-31 to 108.71 on 2025-12-31, up 9%.

Sales is at 239, Profit is at 71, Shares in issue is at 109, against 100 in 2016.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-20

Sales, where the first year is 100239
Source
filed
Statement
income
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
The filing itself
Profit, where the first year is 10071
Source
filed
Statement
income
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
The filing itself
Shares in issue, where the first year is 100109
Source
filed
Statement
income
Fiscal year
2025
Accession
0001551152-26-000008
Reported in
USD
The filing itself